AgeX Therapeutics , Inc. , a biotechnology company developing therapeutics for human aging and regeneration, announced today that on April 20, 2023 it received a letter from the staff of the NYSE. | April 26, 2023
/PRNewswire/ China Pharma Holdings, Inc. (NYSE American: CPHI) ("China Pharma," the "Company" or "We"), a specialty pharmaceutical company, today announced.
/PRNewswire/ China Pharma Holdings, Inc. (NYSE American: CPHI) ("China Pharma," the "Company" or "We"), a specialty pharmaceutical company, today announced.
For the readers interested in the stock health of China Pharma Holdings Inc. (CPHI). It is currently valued at $0.15. When the transactions were called off in the previous session, Stock hit the highs of $0.15, after setting-off with the price of $0.13. Company’s stock value dipped to $0.13 during